19 Jan
2021

Six life sciences IP dealmaking trends to watch out for in 2021

Following a turbulent 2020, it is difficult to anticipate the scale of biotech and pharma transactions in 2021. But several value-creation trends can be reliably predicted

Adam Houldsworth

Author | Life sciences reporter

[email protected]

Adam Houldsworth